Sidra Medicine is set to host the 12th edition of the Precision Medicine and the Future of Genomics (PMFG) Summit from December 7 to 9, 2026, at the Qatar National Convention Centre (QNCC), bringing together global experts to examine emerging developments in genomics, artificial intelligence and precision healthcare.
The summit marks 12 years of advancing discussions around precision medicine and genomics in Qatar and the wider MENA region. This year’s programme will focus on four scientific pillars, including population-scale genomic infrastructure, AI-driven discovery and regulatory frameworks, genomics for rare and inherited diseases, and translating genomic discoveries into accessible and equitable patient care.
Click here to join our WhatsApp channel here
Artificial intelligence will feature prominently throughout the programme, covering areas such as AI-assisted drug discovery, quantum computing for genomic analysis, disease-risk prediction and cross-border research using privacy-preserving approaches.
Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine and Executive Chair of PMFG Summit 2026, said: “Since hosting the first major precision medicine symposium in the Middle East in 2014, Sidra Medicine has continued to lead regional and global dialogue on personalized healthcare. Since then, PMFG has evolved alongside the remarkable progress Sidra Medicine has made in precision medicine and genomics. We are now at a pivotal stage where advances in genomics, artificial intelligence and data science are creating new opportunities to transform how we predict, diagnose and treat disease. Through PMFG Summit 2026, we want to bring together global expertise to accelerate the translation of these discoveries into meaningful improvements in patient care.”
The summit will also address how regulators, healthcare systems and society can responsibly manage the rapid development of AI-driven medicine. Sessions will include live debates, specialist workshops, scientific poster presentations and networking opportunities designed to encourage collaboration between researchers, clinicians and technology experts.
The event will bring together clinicians, pediatricians, researchers, geneticists, data scientists, public health officials, policymakers, biotechnology innovators and industry leaders to discuss the future of precision medicine and genomic healthcare.
Also read: Hospital Investment to Expand Healthcare Capacity in Dubai
Dr. Ammira Akil, Principal Investigator and Director of Metabolic and Mendelian Translational Program at Sidra Medicine and Managing Chair of PMFG Summit 2026, said: “For decades, most genetic research has focused on a small part of the world’s population. This year’s PMFG Summit is bringing together the scientists that are changing that landscape. We will have esteemed researchers who have built or are building genetic maps that finally include African, Chinese and Vietnamese ancestry. We will also feature experts launching national genome projects across the Global South in places like Pakistan, Egypt, Peru and Ghana, and here in Qatar, including updates about newborn screening programs in populations where genetic conditions are more common. The core focus of the summit will be to address the most important question of all: will this reach every patient who needs it, no matter where they live?”
